Schizophrenia
Published on 26. August 2010
Book
Hardback
260 pages
978-1-84692-035-6 (ISBN)
Description
The care of patients with schizophrenia integrates the skills of a wide range of healthcare professionals. Psychiatrists, psychologists, psychiatric nurses and social workers, provide multidisciplinary care involving the use of drugs, psychosocial therapy and behavioural therapy, either in the hospital or in the patient's home environment.This new volume updates the reader on the therapeutic options available, with special emphasis on the new generation of 'atypical' antipsychotic drugs, their mode of action and clinical efficacy in a range of applications. These new agents are compared with existing medications, to guide the reader on their use in combination with other treatments as part of an integrated programme of patient management. This book addresses special topics such as cognitive impairment, early psychosis, compliance and emergencies; explains mechanisms of drug action and their clinical applications; and, addresses key questions in therapeutic decision making.
Reviews / Votes
"This book is unique in its straightforward and honest account of the current state of affairs in the treatment and management of patients with this devastating illness. I highly recommend it." Michael Schrift, University of Illnois at Chicago College of MedicineMore details
Series
Language
English
Place of publication
Oxford
United Kingdom
Target group
Professional and scholarly
Illustrations
diagrams, halftones, charts, tables
Dimensions
Height: 240 mm
Width: 170 mm
ISBN-13
978-1-84692-035-6 (9781846920356)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Content
1. Metabolic and endocrine effects of antipsychotic agents: scientific theory and clinical practice, V Frighi; 2. Cognitive impairment in schizophrenia and treatment strategies for it, C Pantelis, P Maruff, R Testa; 3. Dual diagnosis treatment strategies, N Seivewright; 4. Long-acting antipsychotic drugs: do they improve outcome? P Haddad; 5. Issues in the development of antipsychotic drugs: the current climate, A Mortimer; 6. CBT and other psychological strategies in schizophrenia, P McKenna; 7. Treatment strategies in early psychosis, S Lewis; 8. Structural and functional imaging in schizophrenia: implications for pathophysiology, E Pomarol-Clotet; 9. Functional imaging with ligands in schizophrenia: therapeutic inferences, O Howes, S Kapur; 10. Adjunctive treatment in schizophrenia: what is the evidence? R Conley; 11. The current status of clozapine in and beyond treatment resistant schizophrenia, R Buchanan; 12. Neurochemical theories of schizophrenia, P McKenna; 13. Atypical vs. conventional treatment in schizophrenia in practice: another triumph of hope over experience? PB Jones; 14. Basic mechanisms of atypical antipsychotic drug action, J Waddington; 15. The hyperacute/behaviourally disturbed patient: rapid tranquillisation and other strategies, S Dye; 16. Compliance in schizophrenia, P Weiden; Abbreviations; Index.